An excerpt from LCGC’s e-learning tutorial on optimizing size-exclusion chromatography (SEC) for biologics analysis at CHROMacademy.com
An excerpt from LCGC’s e-learning tutorial on optimizing size-exclusion chromatography (SEC) for biologics analysis at CHROMacademy.com
Parameters such as pore size, column dimensions, temperature, flow rate, and mobile phase are important to consider when developing robust size-exclusion chromatography (SEC) methods because many of these can impact the level of aggregation detected.
Choosing the optimum pore size for your molecules of interest is very important. You need to ensure the protein monomers and dimers are physically able to permeate the pore structure to obtain a separation. One rule of thumb is that the pore size of the column should be three times the diameter of the molecules of interest. If the pore size is too small, the protein molecules will be excluded from the pores and will be eluted in the void volume of the column, which will result in inaccurate quantitative data. Conversely, if the pore size is too large all of the proteins will be able to fully permeate the particles and there will be very little separation. Because the choice of pore size influences the resolution obtained when using SEC, testing a range of pore sizes to match this to the analytes is worthwhile.
Column internal diameter affects the flow rate and injection volume. There are two common column internal diameters in SEC: 4.6 and 7.8 mm. Since the separation mechanism is purely based on diffusion into and out of the pores of the stationary phase, the greatest separation comes from having larger column sizes. Using a slow flow rate allows the molecules sufficient time to diffuse into and out of the static pool of mobile phase contained within the pore structure. The normal flow rate for a 7.8-mm i.d. SEC column is 1.0 mL/min. This translates to 0.35 mL/min when using a smaller 4.6âmm i.d. column. The internal diameter difference also means the amount of sample injected on a 4.6âmm i.d. column can be reduced by a similar amount (~33%), which is useful if you have a limited amount of sample available. It is important to recognize that operating 4.6-mm i.d. columns at 0.35 mL/min can lead to differences in performance related to the extracolumn dead volume in the system; peaks can become broader if long capillaries with wide bores are used to connect the injection valve to the column or the column to the detector. Longer columns provide more resolution, but require longer run times. Shorter columns produce shorter run times, greatly increasing throughput (for even faster separations, use higher flow rates). Since separation relies on the available pore volume, using longer columns or multiple columns in series increases the available pore volume and therefore increases resolution. Going from a 30-cm column to a 15-cm column means the run time can be cut in half. As long as you still have the required amount of resolution, using a shorter column can greatly improve sample throughput. Sample throughput may be particularly important to you if you are screening multiple samples during early development phases, or taking regular measurements from a fermentation.
Temperature is sometimes overlooked in simple approaches such as the isocratic methods used in SEC. Methods often state the temperature simply as ambient. However, it is highly desirable to use a column oven if you are looking at ensuring good reproducibility. In a laboratory environment where the ambient temperature could change more than 10 °C during the course of the day or night, you will see a noticeable impact. This difference in temperature will change the viscosity of the mobile phase significantly, which in turn will change the column operating pressure, and the diffusion process into and out of the pore structure will also change. The temptation is to increase the temperature-higher temperatures will mean significantly lower viscosity, much lower operating pressures, and much faster diffusion, giving sharper peaks and better resolution. However, if the temperature is too high, more aggregation is likely to result-precipitation of the sample before analysis may even occur because of exposure to excessive temperature.
Chromatographers who work with reversed-phase separations are used to operating at high flow rates and achieving optimum plate counts for small molecules (for example, 1.1–1.2 mL/min on a 300 mm × 7.8 mm column). However, when you start to look at the column efficiency for larger molecules, such as proteins, the optimum flow rate is much lower (in this case, 0.6 mL/min compared to 1.2 mL/min for the previous example). This flow rate difference of course means that the run times will be considerably different.
Mobile-phase selection can have a noticeable effect on some proteins, with differences in ionic strength, pH, and buffer composition resulting in changes in resolution, selectivity, and peak shape. It is therefore essential to consider what effect even minor changes in buffer composition may have to demonstrate method robustness and method optimization. Particular care needs to be taken with detergents and other denaturants because they can cause proteins to unfold and become larger in solution, or can bind to such an extent that molecular weight and size in solution increase dramatically, which leads to shorter retention times. Different columns might behave differently too; most are silica-based and it is common to see undesirable interactions occurring at low ionic strength. However, as you increase ionic strength you may also begin to see other effects; hydrophobic interactions may start to occur as you move towards conditions that begin to look like hydrophobic interaction chromatography.
Get the full tutorial at www.CHROMacademy.com/Essentials (free until 20 April).
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.